UNODC INFORMAL INTERNATIONAL SCIENTIFIC NETWORK. Dealing with the world drug problem with the help of science

Similar documents
INFORMAL SCIENTIFIC NETWORK STATEMENT: United Nations General Assembly Special Session on Drugs (UNGASS 2016)

BACKGROUND AND RATIONALE

GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy

CND UNGASS FOLLOW UP

Global EHS Resource Center

Undetectable = Untransmittable. Mariah Wilberg Communications Specialist

REVISED ELEMENTS - PROPOSED BY THE UNGASS BOARD TO THE CND FOR FURTHER CONSIDERATION - STATUS 4 November 2015

Identifying Common Ground on Public Health for UNGASS 2016:

Side events. 2:20-3:10 Development Oriented Drug Policies: The Future of Alternative Development

THE CARE WE PROMISE FACTS AND FIGURES 2017

PROMOTION AND PROTECTION OF ALL HUMAN RIGHTS, CIVIL, POLITICAL, ECONOMIC, SOCIAL AND CULTURAL RIGHTS, INCLUDING THE RIGHT TO DEVELOPMENT

Sperm donation Oocyte donation. Hong Kong þ Guideline þ þ Hungary þ þ þ þ Israel þ þ þ þ Italy þ þ þ. Germany þ þ þ þ Greece þ þ þ þ

Gender inequality and genderbased

Expert consultation on improving drug statistics and strengthening the Annual Report Questionnaire (ARQ)

Terms and Conditions. VISA Global Customer Assistance Services

Co-ordination, monitoring and evaluation of drug policies. Bob Keizer. Senior Drug Policy Advisor. Trimbos-instituut

Expert consultation on the improvement of drug statistics and to strengthen the Annual Report Questionnaire (ARQ) UNODC Concept Note

Pharmaceutical, Medical and Health-related Government and Regulatory bodies around the world.

Economic and Social Council

25 September 2012 Early Years Pathfinder. misuse. Insert name of presentation on Master Slide. Presenter: Dr Sarah J Jones

Country-wise and Item-wise Exports of Animal By Products Value Rs. Lakh Quantity in '000 Unit: Kgs Source: MoC Export Import Data Bank

Smokefree Policies in Europe: Are we there yet?

Current State of Global HIV Care Continua. Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2

Uruguayan Position before UNGASS 2016: Strategic axes for a comprehensive approach to drug policy

o Dental Implants Market By Material, Type, Structure Global Forecast To 2022 Report ID: MRDH Publishing Date: July, 2017

Population- based cancer survival estimates

The UNODC Early Warning Advisory On NPS 2 nd Annual Meeting Copolad II

Available Hepatitis Information: how can this be used to convince decision makers and potential funders

International cooperation against the world drug problem. of human rights overrules the harm caused by drugs. Eradication of production and

Enriched RWE study in the Nordics a case study

Republic of Turkey- Ministry of Interior-Turkish National Police- Counter Narcotics Department Date of submission: Contact person:

COUNCIL. Official Journal of the European Union. (Information) EU Drugs Action Plan ( ) (2005/C 168/01) Introduction

World Connections Committee (WCC) Report

Donne e addiction: La prospettiva di genere nella medicina delle dipendenze AULSS 9 Treviso 7 ottobre 2016

Main developments in past 24 hours

Field of Post-M.D. Training

Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE (LUNG-SAFE)

DRAFT OUTCOME DOCUMENT (14 JANUARY 2016) UNGASS

Media Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences

WCPT COUNTRY PROFILE December 2017 SWEDEN

[co-sponsors of events will be added after written confirmation]

West Nile Disease. World situation and impact on public health

EU Market Situation for Poultry. Committee for the Common Organisation of the Agricultural Markets 20 April 2017

FOURIER STUDY GREYLOCK PRESS: CTS PRODUCT SAMPLE - FOURIER YES. Did the study achieve its main objective?

WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 SERBIA

Injection Techniques Questionnaire (ITQ) WorldWide Results Needle Gauge

International Standards of Drug Use Prevention

Louisville '19 Attachment #69

United Nations Office on Drugs and Crime (UNODC)

Commission on Narcotic Drugs

HIV AND PEOPLE WHO INJECT DRUGS

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

Drug Trafficking and Abuse - Impediments to development - Akira Fujino United Nations Office on Drugs and Crime (UNODC)

Alcohol-related harm in Europe and the WHO policy response

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe

- Network for Excellence in Health Innovation

Making the world safer from drugs, crime and terrorism

BEYOND 2008 DECLARATION

ESPEN Congress Geneva 2014 FOOD: THE FACTOR RESHAPING THE SIZE OF THE PLANET

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

WELLNESS COACHING. Wellness & Personal Fitness Solution Providers

PLACEMENT AND TREATMENT OF MENTALLY ILL OFFENDERS LEGISLATION AND PRACTICE IN EU-MEMBER STATES

Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c. VARIANT II TURBO Link. Fully-Automated HbA 1c Testing

1 See also CND s input provided to the 2016 High-level Political Forum on the theme Ensuring that no one is left behind.

EMBARGOED UNTIL 22 JUNE PM CEST (GMT+2)

International Drug Control Conventions. Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol

Allied Health: Sustainable Integrated Health Care for all Australians

What is the extent of gender bias in bioinformatics?

Engagement in language assessment / Regions of Europe

PMINJ Chapter May 4 th Symposium Straight-Up Emotional Intelligence

Molecular Diagnostics Market Share, Size, Analysis, Growth, Trends and Forecasts, 2016 to 2024 Hexa Research

Drug Prices Report Opioids Retail and wholesale prices * and purity levels,by drug, region and country or territory (prices expressed in US$ )

General Assembly. United Nations A/65/L.27. Global health and foreign policy. Distr.: Limited 1 December Original: English

Requirements of the International Drug Control Conventions, Catherine Muganga Legal Officer, UNODC Feb 2015

TasP - Individual versus Public Health Benefit versus Both.

A Summary of Childhood Cancer Statistics in Australia,

Emerging Risks Mapping of Activities in Member States. 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018

BioPlex 2200 Infectious Disease Panels

CYCLOTRONS WORLD MARKET REPORT & DIRECTORY EDITION TOC and Summary USED IN NUCLEAR MEDICINE MARKET DATA, COMPANIES PROFILES.

Economic and Social Council

GLP in the European Union Ecolabel detergents, GLP and accreditation

The European network for paediatric research. Carlo Giaquinto University of Padova Padova

Procedure for Expedited Review of imported pre-qualified vaccines for use in national immunization programmes

Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c. VARIANT II TURBO Link System. Fully-Automated HbA 1c Testing

WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017

The first and only fully-automated, multiplexed solution for Measles, Mumps, Rubella and Varicella-zoster virus antibody testing

Ethics education: global, inspiring and challenging

Brigitte Khoury, Ph.D. Director, Arab Regional Center for Research, Training and Policy Making in Mental Health Dept. of Psychiatry, American

Overview of drug-induced deaths in Europe - What does the data tell us?

508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender

Prevention, treatment and health care. UNGASS Outcome Implementation. Gilberto Gerra Chief Drug Prevention and Health Branch

Access to pain therapy in the UN resolutions: worldwide perspective

Chemical compatibility of the Pall QPoint TM Docking Station - Tap Assembly with common surface disinfectants

Transcription:

UNODC INFORMAL INTERNATIONAL SCIENTIFIC NETWORK Dealing with the world drug problem with the help of science

The complexity of drug use and drug use disorders

Substantive challenges Children protection and support to families, particularly the most vulnerable Prevention based on scientific methods Access to qualified treatment for drug use disorders and HIV/Hepatitis From the criminal justice to the public health perspective Access to controlled drugs, indispensable for medical purposes Systematic data collection and evaluation Early warning system / forensic analyses : NPS Response to vulnerabilities: women, children, refugees Intelligence strategies against drug trafficking

More research on psychosocial and pharmacological treatment methods

Gene expression changes with acetylation affect behavioural sensitivity to cocaine, potentiating the rewarding effects of cocaine

Poverty and stress during childhood: - hyperactive amygdala (emotions store) - hypoactive prefrontal cortex (emotions regulation) Luan Phan et al., 2013

Mephedrone Mephedrone induces dopamine/norepinephrine release Stimulant effects Teeth grinding, cardiovascular problems, behavioural undercontrol

Rationale for the Network Bridging the gap between science, policy and practices to deal with the world drug problem. Provision of science based information to law makers and policy makers.

What is known What is known is not what is adopted to help children, families, and individuals affected What is adopted is not used with fidelity and good, measurable outcomes. What is used with fidelity is not sustained for a useful period of time. What is used with fidelity is not used on a scale sufficient to impact problems.

The evidence Important decisions are often made with insufficient input from the scientific community Discussions and decisions are often politically and ideologically driven

A strong mandate: The establishment of the Informal International Scientific Network is supported by the Resolution 58/7 Strengthening cooperation with the scientific community, including academia, and promoting scientific research in drug demand and supply reduction policies in order to find effective solutions to various aspects of the world drug problem

Members of the Informal International Scientific Network Appointed by the Member States, scientists from: Algeria Argentina Austria Brazil Bulgaria China Colombia Egypt France Germany Ghana India Israel Italy Kenya Lebanon Mexico Morocco Norway Poland Portugal Russia Spain Sweden Switzerland Uganda United States

Presentation of the Statement by the Informal International Scientific Network to the Commission on Narcotic Drugs

Statement by the Informal International Scientific Network to the CND substance use disorders are determined by the interface of developmental, biological, neuro-psychological, social, and cultural factors. elimination of stigma and discrimination of individuals with substance use disorders. criminal sanctions are not beneficial in addressing substance use disorders and discourage their use. collect and analyse reliable information on patterns of substance use and substance related problems

Substance use disorders are preventable and effective prevention programs do exist. Effective prevention programs that should be initiated as early as possible during childhood and to implement/scale-up programs. Substance use disorders are treatable and should be considered as a public health issue Treatment should be science based, ethical, voluntary based Treatment should integrate pharmacological and psychosocial methods.

UNGASS A discussion paper prepared by the scientists within the CND 2016. Hearing of the informal scientific network at the UNGASS 2016 Possible engagement of scientists in the thematic roundtables Informal consultation during the UNGASS

E-mail gilberto.gerra@unodc.org Twitter @gilbertogerra